Iterative Health was recognized in the computer-aided imaging category for its artificial intelligence-based imaging research.
It was chosen out of a pool of 13,000 companies, evaluated on research and development activity, market potential, business relationships, investor profiles, team strength and technology novelty.
“2022 has been a transformative year for Iterative Health, from FDA clearance of our first product, to growing the team by over fivefold and adding some incredible talent to our team. This award demonstrates the tremendous effort our team puts in everyday to develop technology that will benefit patients everywhere,” Jonathan Ng, founder and CEO of Iterative Health, said in a Dec. 7 press release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.